The mechanism by which Nrf2 promotes thyroid cancer proteasome inhibitor resistance is not limited to the interaction with apoptosis regulators (ATF4, ORP150, etc.)but also includes direct regulation of cell redox status. The gene discussed is NFE2L2; the disease is thyroid gland carcinoma.